Nuvation Bio Inc. (NUVB) earnings date
Mar 4, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 45% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 37 days, typically, give or take 13 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Nov 4, 2026 | after close | 35 | 8-K |
| Q2 FY2026 | Thu, Aug 6, 2026 | before open | 37 | 8-K |
| Q1 FY2026 | Mon, May 4, 2026 | after close | 34 | 8-K |
| Q4 FY2025 | Mon, Mar 2, 2026 | after close | 61 | 8-K |
| Q3 FY2025 | Mon, Nov 3, 2025 | after close | 34 | 8-K |
| Q2 FY2025 | Thu, Aug 7, 2025 | before open | 38 | 8-K |
| Q1 FY2025 | Wed, May 7, 2025 | after close | 37 | 8-K |
| Q4 FY2024 | Thu, Mar 6, 2025 | after close | 65 | 8-K |
What they guided beta
| Q3 FY2025 | "The Company expects to provide an update from the Phase 1/2 dose escalation study of NUV-1511 by year end 2025." exhibit |
| Q3 FY2025 | "The Company anticipates taletrectinib will be listed on China’s National Reimbursement Drug List in 2026." exhibit |
| Q2 FY2025 | "The Company expects to provide an update from the Phase 1/2 dose escalation study of NUV-1511 in the second half of 2025." exhibit |
| Q2 FY2025 | "We expect patients on this program to generate full commercial revenue in their second month on IBTROZI, and therefore in the third quarter of 2025." exhibit |
| Q2 FY2025 | "The Company anticipates taletrectinib will be listed on China’s National Reimbursement Drug List in 2026." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/NUVB
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/NUVB
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/NUVB/"><img src="https://veritasdata.dev/embed/NUVB.svg" alt="NUVB earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/NUVB/)
Script
<script async src="https://veritasdata.dev/embed/NUVB.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/NUVB"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.